SCHEMBL2862999

SCHEMBL2862999

O=C(O)c1cc2c(-c3cc4ccccc4s3)n[nH]c2cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.47
MAPKAPK2 P49137 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
IKBKB O14920 3/20 0.40
BCL2L1 Q07817 1/20 0.39
CHUK O15111 1/20 0.38
IKBKG Q9Y6K9 1/20 0.38
MAP2K4 P45985 2/20 0.37
ACLY P53396 2/20 0.37
ERN1 O75460 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862938 0.84 MAPK10 (0.50) MAPK10MAPKAPK2SIRT2SIRT1PIP5K1C
SCHEMBL2862326 0.84 KDM4E (0.46) MAPK10MAPKAPK2SIRT2SIRT1CA12
SCHEMBL2861529 0.81 MAPKAPK2 (0.53) MAPK10MAPKAPK2SIRT2SIRT1IKBKB
SCHEMBL2863181 0.81 MAPKAPK2 (0.48) MAPK10MAPKAPK2SIRT2SIRT1CA1
SCHEMBL2862092 0.81 MAPK10 (0.49) MAPK10MAPKAPK2SIRT2SIRT1PIP5K1C
SCHEMBL2860415 0.80 MAPK10 (0.54) MAPK10MAPKAPK2SIRT2SIRT1IKBKB
SCHEMBL4326727 0.80 TRPV3 (0.47) MAPK10MAPKAPK2SIRT2SIRT1PIP5K1C
SCHEMBL2859049 0.80 MAPK10 (0.43) MAPK10MAPKAPK2SIRT2SIRT1CA12
SCHEMBL4334072 0.79 HPGD (0.47) MAPK10MAPK1
SCHEMBL4341432 0.79 ALDH1A1 (0.47) MAPK10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK10 29/4885MAPKAPK2 18/4885SIRT2 1519/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAPK10 27/4885MAPKAPK2 26/4885SIRT2 2133/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK10 29/4885MAPKAPK2 18/4885SIRT2 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.